Brief: Bioventus reports Q4 sales USD 125.8 million
31/03/2023 12:35
Mar 31 (Reuters) - Bioventus Q4 adjusted operating income USD 11.8 million. * Q4 adjusted gross profit USD 89.6 million * Q4 net income USD -44.9 million * Q4 adjusted EBITDA USD 15.2 million * Q4 adjusted EPS USD -0.06 * Q4 sales USD 125.8 million
Recent news on Bioventus
See all newsBioventus Q1 revenue rises 7%, beats expectations
U.S. STOCKS ON THE MOVE -Erasca Inc, Regenxbio, Natgas stocks
U.S. STOCKS ON THE MOVE-American Eagle Outfitters, gold miners, EPAM
U.S. STOCKS ON THE MOVE -Burlington Stores, Berkshire Hathaway, Bioventus
Bioventus rises after better-than-expected quarterly results